Abstract Objective: This study aimed to examine the clinical risk factors for cephalosporin resistance in patients with Gram-negative bacteremia caused by Escherichia coli (EC), Klebsiella pneumoniae (KP), Enterobacter cloacae (ENC), and Pseudomonas aeruginosa (PS). Methods: retrospective cohort included 400 adults bacteremia. The goal was review 100 cases involving each species approximately h...

IntroductionAntimicrobial treatments for carbapenem-resistant Enterobacteriaceae (CRE) bacteremia are limited, with colistin-based regimens being a primary therapy. Ceftazidime–avibactam is an emerging treatment various CRE infections. Our study aimed to assess ceftazidime–avibactam effectiveness compared colistin in patients bacteremia.MethodsThis retrospective, multi-centre included adult tre...

conclusions invasive interventions increased bacteremia susceptibility in burn wards. mortality rate had a direct association with bacteremia prevalence and increased by larger burn area. results thirty-nine males (48.1%) and 42 females (51.9%) included with a mean age of 32.06 ± 17.46 years. in patients without bacteremia, 57 patients did not need catheterization (89.1%), however in patients w...

introduction: the aims of the present study were: [1] to evaluate whether erbium-doped: yttrium, aluminum and garnet (er: yag) laser could be a prophylactic methods against transient bacteremia during scaling and root planing (srp) [2] to confirm the efficacies of srp with er: yag laser by clinical and microbiologic evaluations. methods: twenty chronic periodontitis subjects were randomly treat...

BACKGROUND Staphylococcus aureus bacteremia is a common infection associated with significant morbidity and mortality. Telavancin is a bactericidal lipoglycopeptide active against Gram-positive pathogens, including methicillin-resistant S. aureus (MRSA). We conducted a randomized, double-blind, Phase 2 trial in patients with uncomplicated S. aureus bacteremia. METHODS Patients were randomized...

BACKGROUND Neonatal bloodstream infection (BSI) is the most important cause of morbidity and mortality in the neonatal intensive care unit (NICU). Although most neonatal BSIs are primary bacteremia, some are associated with a focus of infection. This distinction is not well characterized. METHODS All patients with neonatal late-onset sepsis (LOS) between January 2006 and December 2013 were en...

introduction campylobacter jejuni is a slender, motile, non-spore-forming, helical-shaped, gram-negative bacterium. it is one of the most common causes of human gastroenteritis in the world. the aim of this study was to present a patient with acute lymphocytic leukemia (all), who was infected with campylobacter jejuni. conclusions c. jejuni should be considered in the differential diagnosis as ...

Several studies have shown that patients with bacteremia caused by methicillin-resistant Staphylococcus aureus (MRSA) have worse outcomes than those with bacteremia caused by methicillin-susceptible S. aureus (MSSA). However, only a limited number of studies have stratified the MRSA isolates into healthcare-associated (HA-) and community-associated (CA-) MRSA strains in such a comparison. This ...

Vancomycin remains the mainstay treatment for methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSIs) despite increased treatment failures. Daptomycin has been shown to improve clinical outcomes in patients with BSIs caused by MRSA isolates with vancomycin MICs of >1 mg/liter, but these studies relied on automated testing systems. We evaluated the outcomes of BSIs cause...